Date: Dec. 5-6, 2020
The Advanced Lung Disease: Novel Therapies and Controversies Conference provides engaging state-of-the-art multidisciplinary lectures focused on the causes, diagnosis, prevention and treatment of diseases affecting the lungs.
Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Texas Heart Institute designates this live activity for a maximum of 11.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.